177 Lu-DOTA-octreotate injection

177 Lu-DOTA-octreotate injection

Name Description
Indication Treatment of Neuroendocrine tumours, which usually express high density of somatostatin receptors.
Production Monday
Storage 2° – 8° C
Expiration 60 hours after labelling
Half Life 6.65 days
Gamma Energy 208 keV
498 Kev (Beta Max 79%)
Radionuclidic purity >99% Lu-177 at expiry (< 0.1% Lu-177m at expiry)
Specific Activity >10 Ci/mg at labelling
Composition Lu177-DOTA-octreotate
Sodium chloride